Fesoterodine
This medication relaxes the bladder muscle to reduce symptoms of overactive bladder, including frequent urination, urgency, and urge incontinence. It works by blocking muscarinic receptors that trigger unwanted bladder contractions.
Masse moléculaire
411,6000 g/mol
LogP
5,50
TPSA
49,80 Ų
Règle des 5 de Lipinski
Conforme
Mécanisme d'action
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
Structure 2D
Cite this structure
Embed this structure
SMILES
CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1
InChI
InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1
Molecular Formula
C26H37NO3
HBD / HBA
1 / 4
Liaisons Rotatives
11
Atomes Lourds
30
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Foire aux questions
This medication relaxes the bladder muscle to reduce symptoms of overactive bladder, including frequent urination, urgency, and urge incontinence. It works by blocking muscarinic receptors that trigger unwanted bladder contractions.
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
Yes, Fesoterodine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201764. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6918558. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="fesoterodine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/fesoterodine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/fesoterodine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/fesoterodine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="fesoterodine"></drugfyi-drug>